Page last updated: 2024-10-28

hydralazine and Malignant Melanoma

hydralazine has been researched along with Malignant Melanoma in 4 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y1
Song, W1
Shen, L1
Qiu, N1
Hu, M1
Liu, Y1
Liu, Q1
Huang, L1
Babbs, CF1
DeWitt, DP1
Voorhees, WD1
McCaw, JS1
Chan, RC1
Thomas, C1
Counsell, C1
Wood, P1
Adams, GE2
Cole, S1
Stratford, IJ1

Other Studies

4 other studies available for hydralazine and Malignant Melanoma

ArticleYear
Vasodilator Hydralazine Promotes Nanoparticle Penetration in Advanced Desmoplastic Tumors.
    ACS nano, 2019, 02-26, Volume: 13, Issue:2

    Topics: Animals; Hydralazine; Liposomes; Melanoma; Mice; Nanoparticles; Tumor Microenvironment

2019
Theoretical feasibility of vasodilator-enhanced local tumor heating.
    European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:11

    Topics: Animals; Blood Flow Velocity; Computers; Cricetinae; Dogs; Female; Hot Temperature; Hydralazine; Mal

1982
Use of fluorine-19 nuclear magnetic resonance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice.
    Journal of the National Cancer Institute, 1992, Feb-05, Volume: 84, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Fluorine; Fluorocarbons; Hydralazine; Hydrocarbons, Brominated; M

1992
Manipulation of radiobiological hypoxia in a human melanoma xenograft to exploit the bioreductive cytotoxicity of RSU-1069.
    International journal of radiation biology, 1989, Volume: 56, Issue:5

    Topics: Animals; Cell Hypoxia; Combined Modality Therapy; Constriction; Female; Hydralazine; Melanoma; Mice;

1989